Extendicare (TSE:EXE – Get Free Report) had its price target increased by investment analysts at BMO Capital Markets from C$30.00 to C$38.00 in a research report issued to clients and investors on Wednesday,BayStreet.CA reports. BMO Capital Markets’ price objective would indicate a potential upside of 15.15% from the stock’s current price.
A number of other brokerages also recently weighed in on EXE. Desjardins set a C$34.50 target price on shares of Extendicare and gave the company a “buy” rating in a research note on Wednesday, April 22nd. TD Securities raised shares of Extendicare from a “hold” rating to a “buy” rating and raised their target price for the company from C$19.00 to C$32.00 in a research note on Monday, April 6th. National Bank Financial raised their target price on shares of Extendicare from C$32.00 to C$34.00 and gave the company an “outperform” rating in a research note on Tuesday. Canadian Imperial Bank of Commerce raised their target price on shares of Extendicare from C$22.00 to C$32.00 in a research note on Thursday, April 2nd. Finally, TD raised their target price on shares of Extendicare from C$32.00 to C$39.00 and gave the company a “buy” rating in a research note on Monday. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of C$31.89.
View Our Latest Stock Report on EXE
Extendicare Stock Up 3.2%
Extendicare (TSE:EXE – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported C$0.42 earnings per share for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The business had revenue of C$465.22 million during the quarter. As a group, equities research analysts forecast that Extendicare will post 0.6134729 EPS for the current fiscal year.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
- 3 Sectors That Look Most Vulnerable Ahead of May 15
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
